About FDA
OWH Intramural Research Program
Description: The FDA OWH Intramural Research Program awards research grants for studies to address regulatory research questions to include: (1) health conditions and diseases that solely or disproportionately affect women; and (2) the identification and understanding of sex differences related to the safety or efficacy of FDA-regulated products.
Phase 1
Briefing Status: Completed
Prior Briefing Status: Completed
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2016 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY15 Q3 |
Completed | 6/10/2015 |
2. Complete review of Quad Charts for development of full proposal |
FY15 Q4 |
Completed | 8/30/2015 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY16 Q2 |
Completed | 2/11/2016 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY16 Q2 |
Completed | 3/28/2016 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY16 Q3 |
Completed | 8/15/2016 |
2. FDA researchers submit end of year progress reports for OWH review |
FY17 Q1 |
Completed | 3/1/2017 |
Phase 2
Briefing Status: Completed
Prior Briefing Status: Completed
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2016 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY16 Q3 |
Completed | 5/16/2016 |
2. Complete review of Quad Charts for development of full proposal |
FY16 Q4 |
Completed | 7/11/2016 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY17 Q1 |
Completed | 11/30/2016 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY17 Q2 |
Completed | 1/1/2017 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY16 Q3 |
Completed | 5/1/2016 |
2. FDA researchers submit end of year progress reports for OWH review |
FY17 Q1 |
Completed | 11/1/2016 |
Phase 3
Briefing Status: Completed
Prior Briefing Status: Completed
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2018 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY17 Q3 |
Completed | 4/14/2017 |
2. Complete review of Quad Charts for development of full proposal |
FY17 Q3 |
Completed | 6/26/2017 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY18 Q1 |
Completed | 12/18/2017 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY18 Q1 |
Completed | 2/2/2018 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY17 Q3 (TBD) |
Completed | 5/1/2017 |
2. FDA researchers submit end of year progress reports for OWH review |
FY18 Q1 |
Completed | 11/1/2017 |
Phase 4
Briefing Status: Delayed
Prior Briefing Status: On Track
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2019 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY18 Q2 |
Completed | 4/2/2018 |
2. Complete review of Quad Charts for development of full proposal |
FY18 Q3 |
Completed | 7/2/2018 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY19 Q1 |
Completed | 12/21/2018 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY19 Q2 |
Completed | 2/25/2019 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY18 Q2 |
Completed | 5/1/2018 |
2. FDA researchers submit end of year progress reports for OWH review |
FY19 Q1 5/1/2019 |
Completed | 10/1/2019 |
Phase 5
Briefing Status: On Track
Prior Briefing Status: On Track
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2020 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY19 Q2 |
Completed | 4/2/2019 |
2. Complete review of Quad Charts for development of full proposal |
FY19 Q3 |
Completed | 7/1/2019 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY20 Q1 |
Completed | 12/17/2019 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY20 Q2 |
Completed | 2/28/2019 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY19 Q2 |
Completed | 5/1/2019 |
2. FDA researchers submit end of year progress reports for OWH review |
FY21 Q1 |
Completed | 11/1/2020 |
Phase 6
Briefing Status: On Track
Prior Briefing Status: On Track
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2021 Projects (projects selected in FY21, though most deferred until FY22) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY20 Q2 |
Completed | 4/21/2020 |
2. Complete review of Quad Charts for development of full proposal |
FY20 Q3 |
Completed | 7/1/2020 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY21 Q1 |
Completed | 12/23/2020 |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY21 Q2 |
Completed | 3/1/2021 |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY20 Q3 |
Completed | 5/1/2020 |
2. FDA researchers submit end of year progress reports for OWH review |
FY22 Q1 |
On Track |
Phase 7
Briefing Status: On Track
Prior Briefing Status: On Track
Milestone Description | Milestone Date | Milestone Status | Milestone Completion Date |
---|---|---|---|
A. FY 2022-2023 Projects (new awards) |
|
||
1. Issue funding announcement for intramural studies addressing women's health issues and understanding of sex differences by FDA researchers |
FY21 Q2 |
Completed | 4/1/2021 |
2. Complete review of Quad Charts for development of full proposal |
FY21 Q3 |
Completed | 6/25/2021 |
3. Complete review and scoring of full proposals, including funding recommendations, by OWH intramural reviewers |
FY22 Q1 |
On Track | |
4. Issue award notices and execute funding agreements with FDA researchers for selected intramural studies |
FY22 Q2 |
On Track | |
B. Ongoing Projects |
|
||
1. FDA researchers submit mid-year progress reports for OWH review |
FY21 Q3 |
Completed | 5/15/2021 |
2. FDA researchers submit end of year progress reports for OWH review |
FY23 Q1 |
On Track |
Key Projects Legend
Milestone Status | Definition |
---|---|
Not Yet Started | Work for specific milestone has not yet been started. |
Completed | Milestone and/or overall project is completed. |
On Track | Milestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status. |
On Hold | Milestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status. |
Delayed | Milestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status. |